{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T21:06:32Z","timestamp":1789074392298,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81700318"],"award-info":[{"award-number":["81700318"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016072","name":"Postdoctoral Scientific Research Development Fund of Heilongjiang Province","doi-asserted-by":"publisher","award":["LBH-Q21109"],"award-info":[{"award-number":["LBH-Q21109"]}],"id":[{"id":"10.13039\/100016072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005046","name":"Heilongjiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["LH2023H022"],"award-info":[{"award-number":["LH2023H022"]}],"id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ejphar.2026.179280","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T06:48:09Z","timestamp":1787294889000},"page":"179280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Finerenone ameliorated ventricular remodeling post myocardial infarction in rats by reducing NF-KB pathway-mediated pyroptosis"],"prefix":"10.1016","volume":"1033","author":[{"given":"Xue","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qipei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyu","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanghong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelaier","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8835-5556","authenticated-orcid":false,"given":"Wenxiu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ejphar.2026.179280_bib1","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/eurheartj\/ehaa736","article-title":"Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine","volume":"42","author":"Agarwal","year":"2021","journal-title":"Eur. Heart J."},{"issue":"23","key":"10.1016\/j.ejphar.2026.179280_bib2","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.ejphar.2026.179280_bib3","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1002\/cmdc.201200081","article-title":"Discovery of BAY 94-8862: a nonsteroidal antagonist of the mineralocorticoid receptor for the treatment of cardiorenal diseases","volume":"7","author":"B\u00e4rfacker","year":"2012","journal-title":"ChemMedChem"},{"issue":"3","key":"10.1016\/j.ejphar.2026.179280_bib4","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41401-019-0307-8","article-title":"Kanglexin, a novel anthraquinone compound, protects against myocardial ischemic injury in mice by suppressing NLRP3 and pyroptosis","volume":"41","author":"Bian","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejphar.2026.179280_bib5","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.yjmcc.2021.05.010","article-title":"CircHelz activates NLRP3 inflammasome to promote myocardial injury by sponging miR-133a-3p in mouse ischemic heart","volume":"158","author":"Bian","year":"2021","journal-title":"J. Mol. Cellular Cardiol."},{"issue":"3","key":"10.1016\/j.ejphar.2026.179280_bib6","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0735-1097(99)00630-0","article-title":"Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling","volume":"35","author":"Cohn","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.ejphar.2026.179280_bib7","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1152\/physrev.00022.2018","article-title":"Fundamental mechanisms of regulated cell death and implications for heart disease","volume":"99","author":"Del Re","year":"2019","journal-title":"Physiol. Rev."},{"issue":"4","key":"10.1016\/j.ejphar.2026.179280_bib8","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1161\/HYPERTENSIONAHA.107.100941","article-title":"Immediate mineralocorticoid receptor blockade improves myocardial infarct healing by modulation of the inflammatory response","volume":"51","author":"Fraccarollo","year":"2008","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.ejphar.2026.179280_bib9","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrcardio.2014.28","article-title":"The inflammatory response in myocardial injury, repair, and remodelling","volume":"11","author":"Frangogiannis","year":"2014","journal-title":"Nat. Rev. Cardiol."},{"issue":"27","key":"10.1016\/j.ejphar.2026.179280_bib10","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1093\/eurheartj\/ehac223","article-title":"Left ventricular remodeling post-myocardial infarction: pathophysiology, imaging, and novel therapies","volume":"43","author":"Frantz","year":"2022","journal-title":"Eur. Heart J."},{"issue":"4","key":"10.1016\/j.ejphar.2026.179280_bib11","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1161\/HYPERTENSIONAHA.117.10360","article-title":"Selective mineralocorticoid receptor cofactor modulation as molecular basis for finerenone's antifibrotic activity","volume":"71","author":"Grune","year":"2018","journal-title":"Hypertension (Dallas, Tex: 1979)"},{"issue":"4","key":"10.1016\/j.ejphar.2026.179280_bib12","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1161\/HYPERTENSIONAHA.115.06709","article-title":"Vascular smooth muscle mineralocorticoid receptor contributes to coronary and left ventricular dysfunction after myocardial infarction","volume":"67","author":"Gueret","year":"2016","journal-title":"Hypertension (Dallas, Tex: 1979)"},{"issue":"1","key":"10.1016\/j.ejphar.2026.179280_bib13","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3892\/mmr.2014.2676","article-title":"Lycopene attenuates inflammation and apoptosis in post-myocardial infarction remodeling by inhibiting the nuclear factor-\u03baB signaling pathway","volume":"11","author":"He","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"18","key":"10.1016\/j.ejphar.2026.179280_bib14","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ejphar.2026.179280_bib15","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1038\/nprot.2006.188","article-title":"A rodent model of myocardial infarction for testing the efficacy of cells and polymers for myocardial reconstruction","volume":"1","author":"Huang","year":"2006","journal-title":"Nat. Protoc."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179280_bib16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/FJC.0000000000000091","article-title":"Finerenone, a novel selective nonsteroidal mineralocorticoid receptor antagonist protects from rat cardiorenal injury","volume":"64","author":"Kolkhof","year":"2014","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"18","key":"10.1016\/j.ejphar.2026.179280_bib17","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.030941","article-title":"Mineralocorticoid receptor blocker prevents mineralocorticoid receptor-mediated inflammation by modulating transcriptional activity of mineralocorticoid receptor-p65-signal transducer and activator of transcription 3 complex","volume":"13","author":"Kuyama","year":"2024","journal-title":"J. Am. Heart Assoc."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179280_bib18","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jchf.2014.07.015","article-title":"Mineralocorticoid receptor antagonists modulate galectin-3 and interleukin-33\/ST2 signaling in left ventricular systolic dysfunction after acute myocardial infarction","volume":"3","author":"Lax","year":"2015","journal-title":"JACC Heart failure"},{"issue":"4","key":"10.1016\/j.ejphar.2026.179280_bib19","article-title":"Cardiac reverse remodeling in ischemic heart disease with novel therapies for heart failure with reduced ejection fraction","volume":"13","author":"Leanc\u0103","year":"2023","journal-title":"Life (Basel, Switzerland)"},{"issue":"8","key":"10.1016\/j.ejphar.2026.179280_bib20","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1517\/13543784.2015.1059819","article-title":"Finerenone: third-generation mineralocorticoid receptor antagonist for the treatment of heart failure and diabetic kidney disease","volume":"24","author":"Liu","year":"2015","journal-title":"Expert Opin. Invest. Drugs"},{"issue":"22","key":"10.1016\/j.ejphar.2026.179280_bib22","doi-asserted-by":"crossref","first-page":"13440","DOI":"10.1111\/jcmm.15969","article-title":"Calhex231 ameliorates myocardial fibrosis post myocardial infarction in rats through the autophagy-NLRP3 inflammasome pathway in macrophages","volume":"24","author":"Liu","year":"2020","journal-title":"J. Cell Mol. Med."},{"issue":"6","key":"10.1016\/j.ejphar.2026.179280_bib21","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1159\/000374048","article-title":"Activation in M1 but not M2 macrophages contributes to cardiac remodeling after myocardial infarction in rats: a critical role of the calcium sensing receptor\/NRLP3 inflammasome","volume":"35","author":"Liu","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"issue":"6","key":"10.1016\/j.ejphar.2026.179280_bib23","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1161\/HYPERTENSIONAHA.117.09791","article-title":"Aldosterone target NGAL (neutrophil gelatinase-associated lipocalin) is involved in cardiac remodeling after myocardial infarction through NF-\u03baB pathway","volume":"70","author":"Mart\u00ednez-Mart\u00ednez","year":"2017","journal-title":"Hypertension (Dallas, Tex: 1979)"},{"issue":"1","key":"10.1016\/j.ejphar.2026.179280_bib24","doi-asserted-by":"crossref","first-page":"H530","DOI":"10.1152\/ajpheart.00549.2006","article-title":"Inhibition of NF-{kappa}B improves left ventricular remodeling and cardiac dysfunction after myocardial infarction","volume":"292","author":"Onai","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"12","key":"10.1016\/j.ejphar.2026.179280_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2022.101386","article-title":"Finerenone: a new era for mineralocorticoid receptor antagonism and cardiorenal protection","volume":"47","author":"Parfianowicz","year":"2022","journal-title":"Curr. Probl. Cardiol."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179280_bib26","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12967-023-03873-6","article-title":"GSDMD-mediated pyroptosis dominantly promotes left ventricular remodeling and dysfunction in post-myocardial infarction: a comparison across modes of programmed cell death and mitochondrial involvement","volume":"21","author":"Piamsiri","year":"2023","journal-title":"J. Transl. Med."},{"issue":"24","key":"10.1016\/j.ejphar.2026.179280_bib27","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1056\/NEJMoa2110956","article-title":"Cardiovascular events with finerenone in kidney disease and type 2 diabetes","volume":"385","author":"Pitt","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.ejphar.2026.179280_bib28","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1161\/HYPERTENSIONAHA.109.131110","article-title":"Deletion of mineralocorticoid receptors from macrophages protects against deoxycorticosterone\/salt-induced cardiac fibrosis and increased blood pressure","volume":"54","author":"Rickard","year":"2009","journal-title":"Hypertension (Dallas, Tex: 1979)"},{"issue":"5","key":"10.1016\/j.ejphar.2026.179280_bib29","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1291\/hypres.30.427","article-title":"Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts","volume":"30","author":"Takeda","year":"2007","journal-title":"Hypertens. Res."},{"issue":"8","key":"10.1016\/j.ejphar.2026.179280_bib30","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1161\/CIR.0000000000001052","article-title":"Heart disease and stroke statistics-2022 update: a report from the American Heart Association","volume":"145","author":"Tsao","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2026.179280_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2023.101781","article-title":"Pyroptosis-induced inflammation and tissue damage","volume":"69","author":"Vasudevan","year":"2023","journal-title":"Semin. Immunol."},{"issue":"6","key":"10.1016\/j.ejphar.2026.179280_bib33","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s10557-021-07239-2","article-title":"Colchicine-containing nanoparticles attenuates acute myocardial infarction injury by inhibiting inflammation","volume":"36","author":"Wang","year":"2022","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"5","key":"10.1016\/j.ejphar.2026.179280_bib32","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.4049\/jimmunol.1001252","article-title":"Innated immune function of the adherents junction protein p120-catenin in endothelial response to endotoxin","volume":"186","author":"Wang","year":"2011","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.ejphar.2026.179280_bib34","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.mayocpiqo.2022.09.002","article-title":"Evolution of mineralocorticoid receptor antagonists in the treatment of chronic kidney disease associated with type 2 diabetes mellitus","volume":"6","author":"Wish","year":"2022","journal-title":"Mayo Clinic proceedings Innovations, quality & outcomes"},{"issue":"6","key":"10.1016\/j.ejphar.2026.179280_bib35","doi-asserted-by":"crossref","first-page":"783","DOI":"10.3390\/ph16060783","article-title":"NF-\u03baB in cell deaths, therapeutic resistance and nanotherapy of tumors: recent advances","volume":"16","author":"Wu","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.ejphar.2026.179280_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1558484","article-title":"Immune in myocardial ischemia\/reperfusion injury: potential mechanisms and therapeutic strategies","volume":"16","author":"Xuan","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2026.179280_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1697422","article-title":"Xin-Fu-Kang oral liquid improves cardiac function and attenuates miR-223-associated NF-\u03baB\/NLRP3 pyroptotic signaling in chronic heart failure","volume":"16","author":"Ye","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.ejphar.2026.179280_bib38","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.3892\/mmr.2014.2051","article-title":"IL-33 attenuates cardiac remodeling following myocardial infarction via inhibition of the p38 MAPK and NF-\u03baB pathways","volume":"9","author":"Yin","year":"2014","journal-title":"Mol. Med. Rep."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926007624?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926007624?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:06:52Z","timestamp":1789070812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926007624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":38,"alternative-id":["S0014299926007624"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179280","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Finerenone ameliorated ventricular remodeling post myocardial infarction in rats by reducing NF-KB pathway-mediated pyroptosis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179280","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"179280"}}